CORT
Corcept Therapeutics Incorporated
·
$90.52
Extended — don't chase; wait for a pullback过度拉升 — 勿追高；等待回撤
Terminal终端 ↗
Corcept Therapeutics Incorporated · Health Care
CORT
$90.52
Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders.CorceptTherapeuticsInc.是一家制药公司，致力于发现、开发并商业化治疗严重代谢、精神和肿瘤疾病的药物。
Broken growth成长受损
Mid cap中盘
$10B
Engine stance引擎立场2026-07-20
Extended — don't chase; wait for a pullback过度拉升 — 勿追高；等待回撤
The bottoming setup is not yet confirmed (price still below the 10-day average) and oscillators are already extended/ove筑底形态尚未确认（价格仍位于 10 日均线下方），且摆动指标已过热——此处入场风险较高。等待价格收复 10 日均线且动量趋于稳定后再考虑建仓。
Key Statistics关键统计
Price价格
$90.52
3.7% below 52-week high低于52周高点 3.7%
Market Cap市值
$10B
Normal volume正常成交量
P/E Ratio市盈率
96.3x
28.9x sector median
Beta贝塔
1.72
Moves about 1.7x the market波动幅度约为市场的 1.7 倍
RSI (14)RSI（14）
63
Elevated偏高
Next Earnings下次财报
2026-07-30 (11d)
Volatility Rank波动率分位
29th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
8.2% of float
Performance价格表现
| Period周期 | CORT | S&P 500 | vs Index对比指数 |
|---|---|---|---|
| 1 Week近1周 | -1.5% | -1.5% | In line with the index与指数基本持平 |
| 1 Month近1月 | +10.7% | +0.6% | Beat the index by 10.1 points跑赢指数 10.1 个百分点 |
| 3 Months近3月 | +96.1% | +4.7% | Beat the index by 91.4 points跑赢指数 91.4 个百分点 |
| 6 Months近6月 | +160.6% | +7.8% | Beat the index by 152.8 points跑赢指数 152.8 个百分点 |
| Year to date年初至今 | +137.0% | +9.1% | Beat the index by 127.9 points跑赢指数 127.9 个百分点 |
| 1 Year近1年 | +23.8% | +19.4% | Beat the index by 4.4 points跑赢指数 4.4 个百分点 |
| 3 Years近3年 | +287.8% | +69.4% | Beat the index by 218.4 points跑赢指数 218.4 个百分点 |
Technicals技术面
RSI (14)RSI（14）
63
Elevated偏高
vs 50-day相对50日均线
+20.7% vs 50-day avg
vs 200-day相对200日均线
+48.1% vs 200-day avg
Volatility rank波动率分位
29th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$87.83
Don't chase above不追高于
$90.52
Stop止损
$79.71
Extended — wait for a pullback过度拉伸 — 等待回撤
Earnings财务业绩
11
days until next report天后公布财报
2026-07-30
Estimates being cut预期下调
Earnings call transcripts — coming soon财报电话会议记录 — 即将上线
Valuation估值
| Multiple指标 | CORT | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（历史） | 96.26x | 28.92 | 9% |
| P/B市净率 | 14.81x | 3.52 | 6% |
| P/S市销率 | 12.60x | 3.02 | 7% |
| Earnings yield盈利收益率 | 1.04% | 2.72 | 32% |
| FCF yield自由现金流收益率 | 1.48% | 3.94 | 21% |
| Shareholder yield股东收益率 | 1.80% | 1.89 | 47% |
| EV/EBITDA企业价值/EBITDA | 206.15x | 18.21 | 1% |
| P/FCF市值/自由现金流 | 67.65x | 22.42 | 9% |
Analyst price targets — coming soon分析师目标价 — 即将上线
Financials财务数据
Revenue营业收入
5yr CAGR5年复合增速: 16.6%
Earnings Per Share每股收益
5yr CAGR5年复合增速: -0.7%
Free Cash Flow自由现金流
Margins利润率
15.4%Return on Equity股本回报率
11.9%Return on Assets资产回报率
Leverage杠杆
| Net debt / EBITDA净债务/EBITDA | -2.62 |
| Current ratio流动比率 | 2.92 |
Capital Allocation资本配置
| Buybacks (TTM)回购（TTM） | $172.9M |
| Stock-based comp股权薪酬 | $84.5M |
| Share count change (1y)股数变化（1年） | +0.8% |
Piotroski皮奥特罗斯基 4/8
Altman Z阿尔特曼Z: safe (33.1)
Clean稳健
Snapshot Gauges综合指标
Valuation vs Sector估值相对行业
Expensive vs sector相对行业偏贵
Cheaper than 9% of its sector on blended multiples综合估值倍数低于行业内 9% 的公司
Beta市场敏感度
1.72×
0.21×3×
Moves about 1.7× the market波动幅度约为市场的 1.7 倍
Financial Health财务健康
4/8
Altman阿尔特曼: safe
Weak financial health财务健康状况偏弱
Dividend分红
—
Does not pay a dividend不派发股息
Why Is It Moving为何波动
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Insider cluster activity内部人集中交易
Technical技术面
CORT StochRSI turned up from oversoldCORT StochRSI自超卖区上行
Ownership & Smart Money持仓与聪明钱
Insider activity内部人员活动: -$21.2M net (1 buyers, 5 sellers)-$21.2M 净值（1 买家，5 卖家）
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Activity动作 | % of portfolio组合占比 | As of截至 |
|---|---|---|---|---|
| Perceptive Advisors | A | New position新建仓 | 0.0% | 2026-03-31 |
Signal History信号历史
TURN SIGNALED
BOTTOMING
Jul 16, 2026
CORT StochRSI turned up from oversoldCORT StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $89.72.StochRSI重回20上方 — 下行动量趋缓的最早预警。$89.72。
Jul 14, 2026
CORT took relative-strength leadershipCORT 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $90.47.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$90.47。
Jul 10, 2026
CORT daily MACD crossed downCORT 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $91.88.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$91.88。
Jul 7, 2026
CORT daily MACD crossed upCORT 日线MACD上穿
The daily MACD histogram turned positive — fast and noisy, context rather than a standalone trigger. $94.04.日线MACD柱状图转正 — 快速且嘈杂，仅作背景。$94.04。
Jul 6, 2026
CORT made a new 52-week highCORT 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $91.61.价格创出52周新高 — 全市场关注的动量/趋势极值。$91.61。
Jun 26, 2026
CORT StochRSI turned up from oversoldCORT StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $87.32.StochRSI重回20上方 — 下行动量趋缓的最早预警。$87.32。
Jun 24, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Showing last 15 of显示最近15条，共 212 signals条信号
Factor Profile因子特征
Composite factor score综合因子得分: -0.70
Value价值
-1.1
Quality质量
+0.1
Investment资本投入
+0.5
Shareholder payout股东回报
-0.6
Low volatility低波动
-2.5
Low market beta低市场敏感度
-1.2
Earnings quality盈利质量
+0.0
Short interest空头兴趣
-1.8
Company Profile公司档案
Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders.CorceptTherapeuticsInc.是一家制药公司，致力于发现、开发并商业化治疗严重代谢、精神和肿瘤疾病的药物。
Watch items — what could change the thesis关注项 — 可能改变论点的因素
- Margin compression despite revenue growth
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析，覆盖所有标普500成分股。